Is metoprolol (beta blocker) used for weight control in patients with atrial fibrillation (AF), particularly in older adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

No, metoprolol is not used for weight control in patients with atrial fibrillation, including older adults. Metoprolol is a beta-blocker primarily prescribed to manage AF by controlling heart rate, reducing blood pressure, and decreasing the workload on the heart. The medication works by blocking the effects of adrenaline on beta receptors in the heart, which slows heart rate and reduces the force of heart contractions.

Key Points to Consider:

  • Typical dosing for AF ranges from 25-100 mg twice daily for immediate-release formulations or 50-200 mg once daily for extended-release versions, with dosage adjusted based on patient response and tolerance 1.
  • Some patients may actually experience weight gain as a side effect of metoprolol therapy.
  • For weight management in AF patients, particularly older adults, clinicians typically recommend lifestyle modifications including dietary changes and appropriate physical activity, along with monitoring of any medications that might contribute to weight gain.
  • If weight control is a significant concern for AF patients, this should be discussed with their healthcare provider, as other medication options might be more appropriate when weight management is a priority.

Important Considerations for Older Adults:

  • The prevalence of atrial fibrillation increases with age, affecting more than 8% of those older than age 80 years 1.
  • Older adults may require lower doses of metoprolol due to increased exposure and risk of adverse effects 1.
  • Women with heart failure may require lower doses of beta-blockers, including metoprolol, to achieve optimal therapeutic benefits and minimize adverse effects 1.

From the Research

Metoprolol and Weight Control in Atrial Fibrillation

  • There is no direct evidence to suggest that metoprolol is used for weight control in patients with atrial fibrillation (AF) 2, 3, 4, 5, 6.
  • Metoprolol is a beta-blocker that is commonly used to control heart rate and maintain sinus rhythm in patients with AF 2, 3, 4, 5, 6.

Age of Fibrillation and Metoprolol Use

  • The studies do not provide specific information on the age of fibrillation and metoprolol use 2, 3, 4, 5, 6.
  • However, the studies suggest that metoprolol is effective in controlling heart rate and maintaining sinus rhythm in patients with AF, regardless of age 2, 3, 4, 5, 6.

Comparison of Metoprolol with Other Rate Control Agents

  • Metoprolol has been compared with other rate control agents, such as calcium channel blockers, in patients with AF 4, 5, 6.
  • The studies suggest that metoprolol is effective in controlling heart rate, but may have different effects on heart rate and blood pressure compared to calcium channel blockers 4, 5, 6.
  • One study found that diltiazem, a calcium channel blocker, was more effective in achieving rate control in ED patients with AF, but metoprolol was also effective with no increased incidence of adverse effects 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Use of beta-blockers in atrial fibrillation.

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.